We use cookies to provide useful features and measure performance to improve your experience on our website. By clicking "Accept all" you agree to the use of all cookies. By clicking on "Show settings", you can adjust your selection.
Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials and how a software solution for tumor assessment can improve the quality and reproducibility of data, all while saving time. …
A recent prospective study [1] conducted by researchers at Cincinnati Children’s Hospital Medical Center compared manual 2D, semi-automated 2D, and volumetric measurement strategies for tumor response assessment in diffuse intrinsic pontine gliomas (DIPG). Imaging-related tumor response criteria used to assess DIPGs are based on…
Our COVID-19 reading template is in use for two weeks, and its usage is multiplying. We are grateful for the close cooperation and feedback from existing and new mint Lesion users. Our medical team went through all the available publications and created a reading…
